TEST

Kestra Medical Technologies is a wearable medical device and digital healthcare company that protects cardiac patients with its Wearable Cardioverter Defibrillator (ASSURE). The ASSURE system records and provides autonomous detection and defibrillation for ventricular arrhythmias and other clinically significant arrhythmias which may require clinical intervention. Kestra’s WCD is the only option that is designed specifically to meet the under-served needs of female cardiac patients.

Kestra Medical Technologies

TEST

Insightec is a medical device company creating the next generation of patient care by realizing the therapeutic power of focused ultrasound. The company’s Exablate platform focuses sound waves, safely guided by MRI, to treat patients with movement disorders.

Insightec

TEST

ProfoundBio is a clinical-stage biotechnology company focused on the development of novel antibody-based therapeutics for patients with cancer. Built on internally developed, innovative, and proprietary technology platforms.

ProfoundBio

TEST

LightForce Orthodontics offers a fully personalized 3D printed braces system and digital treatment planning software. The Company is revolutionizing the orthodontic specialty through advanced manufacturing and technology. LightForce launched its first product to the orthodontic community in 2019 and now offers the only fully custom 7-to-7 braces system.

LightForce

TEST

Ceribell is a medical device and artificial intelligence data analytics platform that deploys a cloud-linked, portable electroencephalogram (“EEG”) headband to facilitate rapid point-of-care diagnosis and treatment of life threatening neurological conditions.

Ceribell

TEST

Mission Bio is a life science tools company focused on single cell genomics, proteomics and multi-omics solutions for oncology study and cell and gene therapy development.

Mission Bio

TEST

Aerin Medical is medical technology company focused on the ear, nose and throat market providing non-invasive solutions for the treatment of chronic nasal conditions.

Aerin Medical

TEST

BenevolentAI is a clinical-stage drug discovery company seeking to combine artificial intelligence and machine learning with science to decipher complex disease biology, generate new insights and discover more effective medicines. The company’s computational R&D platform spans each step of the drug discovery process, with a focus on novel disease targets discovery.

BenevolentAI

TEST

Pulmonx focuses on minimally invasive treatments for severe lung disease. The company’s platforms are designed to assess and treat patients with severe emphysema and chronic obstructive pulmonary disease who, despite medical management, are still symptomatic. Pulmonx completed its IPO on the Nasdaq stock market in October 2020.

Pulmonx

TEST

Arbor Biotechnologies is a biotechnology company that aims to discover and develop the next generation of genetic medicines based on wholly owned genomic editors discovered from its machine learning/AI driven discovery platform.

Arbor Biotechnologies